Updates on 503A Compounding: The Impact of Drug Shortages
The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.
Stay updated with breaking news from Temporary Policy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.
The FDA has issued a Federal Register notice explaining how the end of the COVID-19 Public Health Emergency (PHE) declaration will…
The FDA, set to impose large fees on distilleries that were producing hand sanitizer to help combat the pandemic, has backed off after intervention from the federal Department of Health & Human Services.
The July 31, 2022 deadline is rapidly approaching for employers to update the Forms I-9 of employees who presented an expired List B document (establishing the individual's identity)...
The Department of Homeland Security (DHS) recently announced an end to its COVID-19 Temporary Policy for List B Identity Documents (Temporary Policy). Under the Temporary Policy, for...